Role of Minocycline as an Adjunct Neuroinflammatory Modulator in Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials
Conclusions: The results were inconsistent regarding the clinical and neuroprotective role of minocycline in TRD. More study is needed to clarify the pathophysiologic and clinical role of minocycline as an immunomodulator in TRD.Prim Care Companion CNS Disord 2023;25(5):22r03467.Author affiliations are listed at the end of this article.PMID:37713730 | DOI:10.4088/PCC.22r03467
Source: The Primary Care Companion for CNS Disorders - Category: Primary Care Authors: Wisam Al Jumaili Darshini Vora Chintan Trivedi Shailesh Jain Source Type: research
More News: Allergy & Immunology | Brain | Children | Depression | Minocycline | Neurology | Primary Care | Solodyn | Study